0 of 10 Questions completed
You have already completed the assessment before. Hence you can not start it again.
Assessment is loading…
You must sign in or sign up to start the assessment.
You must first complete the following:
0 of 10 Questions answered correctly
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
What makes a cancer a good CAR T-cell candidate?
Which step is not part of the CAR T cell engineering/manufacturing process?
Which of the following is not an FDA approved CAR T-cell therapy?
Which indication is not an FDA –Approved indication for CAR T-cell therapy at this time?
Which were trials done to evaluate CAR T-cell therapy for patients with diffuse large B-cell lymphoma (DLBCL)?
Which of the following is a requirement of a certified CAR-T treatment facility?
Which of the following is/are true regarding bridging chemotherapy in the CAR T-cell treatment process?
On the day of infusion of CAR T-cells, patients should be given prophylactic antibiotics for infection risk.
Which is true of Cytokine Release Syndrome (CRS)?
What is the recommended treatment for Grade 3 neurotoxicity associated with CAR T-cell therapy?